The failing Fontan: Etiology, diagnosis and management

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 6, 2011, Pages 785-793

  Goldberg, David J ^a,b   Shaddy, Robert E ^a,b   Ravishankar, Chitra ^a,b   Rychik, Jack ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cardiac transplantation; congenital heart disease; Fontan operation; heart failure; pediatrics; plastic bronchitis; protein losing enteropathy

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BUDESONIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SILDENAFIL; TISSUE PLASMINOGEN ACTIVATOR;

BRONCHITIS; CARDIOVASCULAR MAGNETIC RESONANCE; CORTICOSTEROID THERAPY; CROUPOUS BRONCHITIS; DIURETIC THERAPY; DRUG METABOLISM; FENESTRATION; FONTAN PROCEDURE; HEART ASSIST DEVICE; HEART CATHETERIZATION; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HEART VENTRICLE FAILURE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; TREATMENT FAILURE;

ANIMALS; BRONCHITIS; EQUIPMENT AND SUPPLIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; PROTEIN-LOSING ENTEROPATHIES; SURVIVORS; VENTRICULAR DYSFUNCTION;

EID: 79959901032     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.75     Document Type: Review

References (48)

1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 26(3), 240-248 (1971)
2. Kreutzer G, Galindez E, Bono H, De Palma C, Laura JP. An operation for the correction of tricuspid atresia. J. Thorac. Cardiovasc. Surg. 66(4), 613-621 (1973)
3. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 96(5), 1507-1512 (1997) (Pubitemid 27375344)
4. Shaddy RE, Boucek MM, Hsu DT et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298(10), 1171-1179 (2007) (Pubitemid 47403103)
5. Nagayama T, Hsu S, Zhang M et al. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload. J. Am. Coll. Cardiol. 53(2), 207-215 (2009)
6. Hsu S, Nagayama T, Koitabashi N et al. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway. Cardiovasc. Res. 81(2), 301-309 (2009)
7. Kass DA, Champion HC, Beavo JA. Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ. Res. 101(11), 1084-1095 (2007) (Pubitemid 350146434)
8. Kass DA. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3? Circulation 116(3), 233-235 (2007) (Pubitemid 47196557)
9. Zhang M, Takimoto E, Hsu S et al. Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. J. Am. Coll. Cardiol. 56(24), 2021-2030 (2011)
10. Guazzi M, Vicenzi M, Arena R, Guazzi MD. PDE5-inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of a 1-year prospective, randomized, placebo-controlled study. Circ. Heart Fail. 1, 8-17 (2010)
11. Goldberg D, Szwasat A, Marino B et al. Abstract 2161: sildenafil improves ventricular performance in children and young adults after the Fontan operation. Circulation 120(Suppl. 18), S603 (2009)
12. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J. Thorac. Cardiovasc. Surg. 115(5), 1063-1073 (1998) (Pubitemid 28224401)
13. Feldt RH, Driscoll DJ, Offord KP et al. Protein-losing enteropathy after the Fontan operation. J. Thorac. Cardiovasc. Surg. 112(3), 672-680 (1996). (Pubitemid 26347022)
14. Thorne SA, Hooper J, Kemp M, Somerville J. Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease. Eur. Heart J. 19(3), 514-520 (1998) (Pubitemid 28120733)
15. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit. Heart Dis. 2(5), 288-300 (2007) (Pubitemid 47423390)
16. Gewillig M. The Fontan circulation. Heart 91(6), 839-846 (2005) (Pubitemid 40769242)
17. Gewillig M, Brown SC, Eyskens B et al. The Fontan circulation: who controls cardiac output? Interact. Cardiovasc. Thorac. Surg. 10(3), 428-433 (2010)
18. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann. Thorac. Surg. 82(2), 695-700 (2006) (Pubitemid 44080020)
19. Bode L, Eklund EA, Murch S, Freeze HH. Heparan sulfate depletion amplifies TNF-a-induced protein leakage in an in vitro model of protein-losing enteropathy. Am. J. Physiol. Gastrointest. Liver Physiol. 288(5), G1015-G1023 (2005) (Pubitemid 40563145)
20. Bode L, Murch S, Freeze HH. Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J. Biol. Chem. 281(12), 7809-7815 (2006) (Pubitemid 43847395)
21. Amadi B, Fagbemi AO, Kelly P et al. Reduced production of sulfated glycosaminoglycans occurs in Zambian children with Kwashiorkor but not marasmus. Am. J. Clin. Nutr. 89(2), 592-600 (2009)
22. Rychik J. Management of protein-losing enteropathy after the Fontan procedure. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 1, 15-22 (1998)
23. Rychik J, Spray TL. Strategies to treat protein-losing enteropathy. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 5, 3-11 (2002) (Pubitemid 38202146)
24. Kelly AM, Feldt RH, Driscoll DJ, Danielson GK. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease. Mayo Clin. Proc. 73(8), 777-779 (1998) (Pubitemid 28359598)
25. Rychik J, Rome JJ, Jacobs ML. Late surgical fenestration for complications after the Fontan operation. Circulation 96(1), 33-36 (1997) (Pubitemid 27298400)
26. Rychik J, Piccoli DA, Barber G. Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am. J. Cardiol. 68(8), 819-821 (1991)
27. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann. Thorac. Surg. 89(3), 837-842 (2010)
28. Apostolopoulou SC, Papagiannis J, Rammos S. Bosentan induces clinical, exercise and hemodynamic improvement in a pre-transplant patient with plastic bronchitis after Fontan operation. J. Heart Lung Transplant. 24(8), 1174-1176 (2005) (Pubitemid 41127216)
29. Costello JM, Steinhorn D, McColley S, Gerber ME, Kumar SP. Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. Pediatrics 109(4), e67 (2002)
30. Rychik J. Forty years of the Fontan operation: a failed strategy. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 13(1), 96-100 (2010)
31. Paridon SM, Mitchell PD, Colan SD et al. A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J. Am. Coll. Cardiol. 52(2), 99-107 (2008) (Pubitemid 351885449)
32. Giardini A, Hager A, Pace Napoleone C, Picchio FM. Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann. Thorac. Surg. 85(3), 818-821 (2008) (Pubitemid 351253528)
33. Giardini A, Specchia S, Tacy TA et al. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am. J. Cardiol. 99(10), 1462-1467 (2007) (Pubitemid 46686646)
34. Mitchell MB, Campbell DN, Ivy D et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J. Thorac. Cardiovasc. Surg. 128(5), 693-702 (2004) (Pubitemid 39388924)
35. Goldberg DJ, French B, McBride MG et al. impact of oral sildenafil on exercise performance in children and young adults after Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123(11), 1185-1193 (2011)
36. Cardarelli MG, Salim M, Love J et al. Berlin heart as a bridge to recovery for a failing Fontan. Ann. Thorac. Surg. 87(3), 943-946 (2009)
37. Rodefeld MD, Boyd JH, Myers CD et al. Cavopulmonary assist: circulatory support for the univentricular Fontan circulation. Ann. Thorac. Surg. 76(6), 1911-1916 (2003) (Pubitemid 37510503)
38. Riemer RK, Amir G, Reichenbach SH, Reinhartz O. Mechanical support of total cavopulmonary connection with an axial flow pump. J. Thorac. Cardiovasc. Surg. 130(2), 351-354 (2005) (Pubitemid 41074164)
39. Myers CD, Mattix K, Presson RG Jr et al. Twenty-four hour cardiopulmonary stability in a model of assisted newborn Fontan circulation. Ann. Thorac. Surg. 81(1), 264-270 (2006)
40. Lacour-Gayet FG, Lanning CJ, Stoica S et al. An artificial right ventricle for failing Fontan: in vitro and computational study. Ann. Thorac. Surg. 88(1), 170-176 (2009)
41. Rodefeld MD, Coats B, Fisher T et al. Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump. J. Thorac. Cardiovasc. Surg. 140(3), 529-536 (2010)
42. Russo P, Wheeler A, Russo J, Tobias JD. Use of a ventricular assist device as a bridge to transplantation in a patient with single ventricle physiology and total cavopulmonary anastomosis. Paediatr. Anaesth. 18(4), 320-324 (2008) (Pubitemid 351328762)
43. Pretre R, Haussler A, Bettex D, Genoni M. Right-sided univentricular cardiac assistance in a failing Fontan circulation. Ann. Thorac. Surg. 86(3), 1018-1020 (2008)
44. Bernstein D, Naftel D, Chin C et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation 114(4), 273-280 (2006) (Pubitemid 44297093)
45. Lamour JM, Kanter KR, Naftel DC et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J. Am. Coll. Cardiol. 54(2), 160-165 (2009).
46. Shaddy RE, Naftel DC, Kirklin JK et al. Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study. Circulation 94(Suppl. 9), II69-II73 (1996) (Pubitemid 26363368)
47. Feingold B, Bowman P, Zeevi A et al. Survival in allosensitized children after listing for cardiac transplantation. J. Heart Lung Transplant. 26(6), 565-571 (2007) (Pubitemid 46818052)
48. Griffiths ER, Kaza AK, Wyler von Ballmoos MC et al. Evaluating failing Fontans for heart transplantation: predictors of death. Ann. Thorac. Surg. 88(2), 558-563 (2009).